Compounds > 2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide
Page last updated: 2024-09-03

2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide and Sensitivity and Specificity

2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide has been researched along with Sensitivity and Specificity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Findlay, I; Jahangir, A; Kurachi, Y; Shen, WK; Terzic, A; Yamada, M1

Other Studies

1 other study(ies) available for 2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide and Sensitivity and Specificity

ArticleYear
YM934, a novel K+ channel opener, activates ATP-sensitive K+ channels in cardiac myocytes.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:3

    Topics: Adenosine Triphosphate; Animals; Benzoxazines; Cells, Cultured; Cyclic N-Oxides; Guinea Pigs; Heart; Heart Ventricles; Ion Channel Gating; Islets of Langerhans; Membrane Potentials; Myocardium; Oxazines; Potassium Channels; Sensitivity and Specificity

1993